Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer?

Publisher： Karger

E-ISSN： 2235-0802|5|4|261-267

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.5, Iss.4, 2016-10, pp. : 261-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospective Study Confirms that Radioiodine Remnant Ablation Is Not Necessary in Low-Risk Differentiated Thyroid Cancer

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2016-01 ,pp. : 7-8

Karger

Access to resources Recommend Favorite

A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2015-11 ,pp. : 44-49

Karger

Access to resources Recommend Favorite

Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer

By  

European Thyroid Journal, Vol. 6, Iss. 3, 2017-01 ,pp. : 160-166

Karger

Access to resources Recommend Favorite

Follicular Thyroid Carcinoma: Disease Response Evaluation Using American Thyroid Association Risk Assessment Guidelines

By  

European Thyroid Journal, Vol. 4, Iss. 4, 2015-0 ,pp. : 260-265

Karger

Access to resources Recommend Favorite

Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients

By  

European Thyroid Journal, Vol. 4, Iss. 2, 2015-06 ,pp. : 82-92

Karger

Access to resources Recommend Favorite